Aciclovir Crystal Nephropathy Mechanism — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Intratubular crystal deposition and obstruction
Aciclovir is poorly soluble in urine and can precipitate as needle-shaped birefringent crystals within the renal tubules and collecting ducts, causing intratubular obstruction and direct tubular injury (crystal nephropathy). Risk factors include high-dose IV administration, rapid infusion, volume depletion, and pre-existing CKD. The crystals are birefringent under polarised light on urine microscopy. Prevention involves adequate hydration (to maintain urine output >100 mL/hr during infusion) and slow infusion rate. Treatment involves stopping aciclovir, aggressive IV hydration, and haemodialysis for severe cases. AKI is usually reversible if recognised promptly. Similar crystal nephropathy occurs with sulphonamides, methotrexate, and indinavir.
Reference: Perazella 2010 – Crystal-Induced AKI; JRCPTB 2022 – Nephrology Curriculum